![]() |
市場調查報告書
商品編碼
1666991
抗菌(酵素)蛋白水解物市場機會、成長動力、產業趨勢分析與預測 2025 - 2034Antimicrobial (Enzymatic) Protein Hydrolysates Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
2024 年,食品和寵物食品應用的全球抗菌蛋白水解物市場規模達到 2.562 億美元,預計 2025 年至 2034 年的複合年成長率為 7.4%。 這一成長主要得益於食品、製藥和個人護理等行業對天然、生物基抗菌劑的需求不斷成長。
隨著消費者越來越意識到合成防腐劑的風險,酵素蛋白水解物因其功能優勢(包括延長保存期限和增強健康特性)而越來越受歡迎。人們對抗生素抗藥性的日益擔憂促使各行各業轉向蛋白質基水解物,這種水解物已被證明可以有效控制有害微生物。此外,生物技術的進步提高了這些水解產物的生產效率,增加了它們的可用性並支持它們在營養保健品和動物飼料等各個領域的應用。
市場範圍 | |
---|---|
起始年份 | 2024 |
預測年份 | 2025-2034 |
起始值 | 2.562億美元 |
預測值 | 5.32億美元 |
複合年成長率 | 7.4% |
抗菌蛋白水解物市場依來源分類,主要分為植物、動物和微生物。動物性蛋白質在 2024 年佔據了最大的市場佔有率,產值為 1.499 億美元,預計到 2034 年將達到 3.069 億美元。來自魚、牛奶和蛋的動物蛋白因其豐富的氨基酸成分和生物活性肽而備受推崇,這些肽具有抗菌特性。這些蛋白質由於其安全性和抑制有害微生物生長的有效性而被廣泛應用於食品保鮮和藥物中。
就形態而言,市場分為液體、粉末和膏狀類別。粉末形式引領市場,到 2024 年將佔據 63% 的佔有率。它們還提供精確的劑量,使製造商能夠更好地控制配方。此外,粉狀水解物適應性很強,因為它們可以重新組織成流體或添加到乾燥混合物中,從而提高其在各種應用中的適用性。
2024 年,美國食品和寵物食品用抗菌(酵素)蛋白水解物市場價值為 5,790 萬美元。人們對合成防腐劑的逐漸棄用,以及對抗菌素抗藥性日益成長的擔憂,進一步推動了藥品和營養保健品對生物基抗菌解決方案的需求。
The Global Antimicrobial Protein Hydrolysates Market for food and pet food applications amassed USD 256.2 million in 2024 and is projected to grow at a CAGR of 7.4% from 2025 to 2034. This growth is primarily driven by the increasing demand for natural, bio-based antimicrobial agents across industries such as food, pharmaceuticals, and personal care.
As consumers become more aware of the risks associated with synthetic preservatives, enzymatic protein hydrolysates are gaining popularity due to their functional benefits, including extended shelf life and enhanced health properties. The growing concern over antimicrobial resistance is prompting industries to turn to protein-based hydrolysates, which have been shown to effectively control harmful microorganisms. Furthermore, advances in biotechnology have improved the production efficiency of these hydrolysates, increasing their availability and supporting their adoption across various sectors, including nutraceuticals and animal feed.
Market Scope | |
---|---|
Start Year | 2024 |
Forecast Year | 2025-2034 |
Start Value | $256.2 Million |
Forecast Value | $532 Million |
CAGR | 7.4% |
The antimicrobial protein hydrolysates market is categorized by source, with the main segments being plant, animal, and microorganisms. The animal-derived segment held the largest market share in 2024, generating USD 149.9 million, and is expected to reach USD 306.9 million by 2034. Animal-based proteins, sourced from fish, milk, and eggs, are highly valued for rich amino acid profiles and bioactive peptides, which show antimicrobial features. These proteins are widely used in food preservation and medications owing to their safety and effectiveness in inhibiting the growth of harmful microorganisms.
In terms of form, the market is divided into liquid, powder, and paste categories. The powder form leads the market, accounting for 63% share in 2024. Powders are preferred due to their stability, which makes them easier to transport and handle across different industries, including food, pharmaceuticals, and cosmetics. They also offer precise dosing, allowing manufacturers better control over formulations. Additionally, powdered hydrolysates are highly adaptable, as they can be reorganized into fluids or added to dry mixes, improving their serviceability in various applications.
U.S. antimicrobial (enzymatic) protein hydrolysates market for food and pet food applications was valued at USD 57.9 million in 2024. This market is growing rapidly due to increasing consumer demand for clean-label, natural ingredients in food products. The shift away from synthetic preservatives, along with heightened concerns about antimicrobial resistance, is further driving the demand for bio-based antimicrobial solutions in both pharmaceuticals and nutraceuticals.